logo image
  • HOME
  • TEVAR-Twin
  • COMPANY
  • CAB
  • PARTNERS
  • NEWS
  • CONTACT

A digital twin technology to revolutionize stent-graft selection for precise, patient-specific surgeries

Achieve perfect procedural outcomes every time with confidence

image

TEVAR-Twin Solution

LEARN MORE
TEVAR-Twin offers digital twins and AI/ML-enabled precision medicine, user-friendly software needing only pre-surgical CT images. It relies on clinically-validated high-fidelity numerical models to guide surgeons in selecting the “best-fit” stent-graft.
PATIENTS

151

digital twins with research collaborations in Politecnico di Milano
Clinical centres

27

in 9 countries across Europe and North America
Patents

2

15 scientific publications on peer-reviewed clinical & engineering journals

About AllStent

LEARN MORE
The AllStent is a MedTech company founded by a team with >50-years experience in numerical modelling through global collaborations with leading vascular surgeons and stent-graft manufacturers. Additionally, we have expertise in MedTech start-up financing and commercialization, and are pursuing US and EU regulatory clearances.

Testimonials

image
Santi Trimarchi, MD Policlinico di Milano Hospital (Italy)
The presence kinking prediction and post-operative validation made the results of the simulation very credible.
image
Javiér Rio Gomez, MD Hospital General Universitario Gergorio Maranon (Spain)
Before simulations, I didn’t expect big changes in stent configuration changing landing zone. It's interesting to realize how landing zone affects on stent expansion
image
Theodoros Kratimenos, MD Evangelismos General Hospital of Athens (Greece)
Preoperative simulation can be a game changer as predicts possible device misalignment and the best strategy for the patient-specific case!

Learn More about our technology

VIEW ALL
image
Prediction of thoracic endovascular aortic repair intervention: proof of concept using digital twin technology
European Journal of Vascular and Endovascular Surgery, 2026
image
Mechanical performance of thoracic aortic stent-grafts: an in vitro and in silico study
Annals of Biomedical Engineering, 2026
image
Validation and verification of high-fidelity simulations of thoracic stent-graft implantation
Annals of Biomedical Engineering, 2022
Read
Read
Read

our partners

image
image
image

Latest News

April 10th, 2025
In the press: "Corriere della Sera"
Surgical stents, plant-based sushi, and instant diagnostics: the startups of Berkeley SkyDeck Europe in search of investors
Read more >>
April 2nd, 2025
AllStent Joins Berkeley SkyDeck Europe, Secures €145k Investment

"We are excited to join SkyDeck and leverage its world-class ecosystem to accelerate our growth and impact in TEVAR surgery", Paul Chipperton, CEO
Read more >>
October 28th, 2024
AllStent Accepted into the ECHO 2025 Experiential Training Program to compete for C$250,000 prize
ECHO Entrepreneurship, Canada, is training the next generation of innovators in all aspects of advancing cardiovascular care. The program aims to bridge the translational gap for cardiovascular innovations.
Read more >>
SEE ALL OUR NEWS
image
Copyright © All rights reserved.
Address
Via Canonica, 25 20154 Milano (MI) Italy
info@allstent.com

We use cookies to enable essential functionality on our website and analyze website traffic. For more information, read our Cookies and Privacy Policy.

Your Cookie Settings

We use cookies to enable essential functionality on our website and analyze website traffic. For more information, read our Cookies and Privacy Policy below.

Cookie Categories
Essential

These cookies are strictly necessary to provide you with services available through our websites.

Analytics

These cookies collect information that is used in aggregate and in an anonymized form to help us understand how our website is being used and how effectively our site is performing.